Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae
- PMID: 32102749
- DOI: 10.1016/j.jmii.2020.01.005
Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae
Abstract
Background: This study aims to investigate the antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae (CPE).
Methods: Five Lactobacillus spp. strains and 18 CPE clinical isolates were collected. Their anti-CPE effects were assessed by agar well diffusion and broth microdilution assay, as well as time-kill test. Finally, the specific anti-CPE mechanism, especially for the effect of organic acids was determined using broth microdilution method.
Results: All of five Lactobacilli isolates displayed the potent activity against most CPE isolates with mean zones of inhibition ranging 10.2-21.1 mm. The anti-CPE activity was not affected by heating, catalase, and proteinase treatment. Under the concentration of 50% LUC0180 cell-free supernatant (CFS), lactic acid, and mix acid could totally inhibit the growth of carbapenem-resistant Klebsiella pneumoniae (CPE0011), and acetic acid could inhibit 67.8%. In contrast, succinic acid and citric acid could not inhibit the growth of CPE0011. While we decreased the concentration to 25%, only lactic acid and mix acid displayed 100% inhibition. In contrast, succinic acid, citric acid and acetic acid did not show any inhibitory effect.
Conclusions: Lactobacillus strains exhibit potent anti-CPE activity, and lactic acid produced by Lactobacillus strains is the major antimicrobial mechanism.
Keywords: Carbapenemase-producing Enterobacteriaceae; In vitro activity; Lactic acid; Lactobacillus; Organic acid.
Copyright © 2020. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflict of interests.
Similar articles
-
Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.Int J Antimicrob Agents. 2021 May;57(5):106330. doi: 10.1016/j.ijantimicag.2021.106330. Epub 2021 Mar 28. Int J Antimicrob Agents. 2021. PMID: 33789129
-
In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae.Antimicrob Resist Infect Control. 2018 Nov 21;7:142. doi: 10.1186/s13756-018-0435-9. eCollection 2018. Antimicrob Resist Infect Control. 2018. PMID: 30479755 Free PMC article.
-
In vivo study assessed meropenem and amikacin combination therapy against carbapenem-resistant and carbapenemase-producing Enterobacteriaceae strains.J Infect Chemother. 2020 Jan;26(1):1-7. doi: 10.1016/j.jiac.2019.10.014. Epub 2019 Nov 15. J Infect Chemother. 2020. PMID: 31735629
-
[Carbapenemase producing Enterobacteriaceae in the Netherlands: unnoticed spread to several regions].Ned Tijdschr Geneeskd. 2017;161:D1585. Ned Tijdschr Geneeskd. 2017. PMID: 29076442 Review. Dutch.
-
[Epidemic increase in the incidence of carbapenemase-producing Enterobacteriaceae in Denmark].Ugeskr Laeger. 2016 Nov 7;178(45):V06160422. Ugeskr Laeger. 2016. PMID: 27855770 Review. Danish.
Cited by
-
Clinical use of tigecycline may contribute to the widespread dissemination of carbapenem-resistant hypervirulent Klebsiella pneumoniae strains.Emerg Microbes Infect. 2024 Dec;13(1):2306957. doi: 10.1080/22221751.2024.2306957. Epub 2024 Jan 30. Emerg Microbes Infect. 2024. PMID: 38240375 Free PMC article.
-
Revealing the Potential Impacts of Nutraceuticals Formulated with Freeze-Dried Jabuticaba Peel and Limosilactobacillus fermentum Strains Candidates for Probiotic Use on Human Intestinal Microbiota.Probiotics Antimicrob Proteins. 2023 Aug 10. doi: 10.1007/s12602-023-10134-x. Online ahead of print. Probiotics Antimicrob Proteins. 2023. PMID: 37561381
-
In Vitro Effect of the Cell-Free Supernatant of the Lactobacillus casei Strain IMAU60214 against the Different Pathogenic Properties of Diarrheagenic Escherichia coli.Microorganisms. 2023 May 18;11(5):1324. doi: 10.3390/microorganisms11051324. Microorganisms. 2023. PMID: 37317298 Free PMC article.
-
Development and Characterization of Hydroxyethyl Cellulose-Based Gels Containing Lactobacilli Strains: Evaluation of Antimicrobial Effects in In Vitro and Ex Vivo Models.Pharmaceuticals (Basel). 2023 Mar 22;16(3):468. doi: 10.3390/ph16030468. Pharmaceuticals (Basel). 2023. PMID: 36986568 Free PMC article.
-
Gut-on-a-Chip for the Analysis of Bacteria-Bacteria Interactions in Gut Microbial Community: What Would Be Needed for Bacterial Co-Culture Study to Explore the Diet-Microbiota Relationship?Nutrients. 2023 Feb 23;15(5):1131. doi: 10.3390/nu15051131. Nutrients. 2023. PMID: 36904133 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
